TIFFANY SALTSMAN: Open Payments
NPI 1710599857 · MUNFORDVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 26 payments from 14 companies in 2025. Trend: 2023 $180 · 2024 $375 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $102 |
| Corium, LLC | 4 | $55 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Novo Nordisk Inc | 2 | $37 |
| Cipher Pharmaceuticals US LLC | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: CAPLYTA, Azstarys, TRELEGY ELLIPTA, REXULTI, Natroba, FANAPT, Rybelsus, OTEZLA.
Industry payments across KY — which companies pay providers there.
